Insulin aspart, recombinant Subcutaneous and Milk thistle
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Milk thistle and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Millipred
- Insulin aspart, recombinant Subcutaneous-Millipred DP
- Insulin aspart, recombinant Subcutaneous-Millipred Tablets
- Insulin aspart, recombinant Subcutaneous-Milnacipran
- Insulin aspart, recombinant Subcutaneous-Milnacipran Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Milrinone
- Milk thistle-Insulin degludec
- Milk thistle-Insulin Degludec (U-100) Prefilled Pens
- Milk thistle-Insulin Degludec (U-100) Vials
- Milk thistle-Insulin Degludec (U-200) Prefilled Pens
- Milk thistle-Insulin degludec and liraglutide
- Milk thistle-Insulin degludec and liraglutide Subcutaneous